Gould Terry P
Insider CIK 1553470 · OMED Director · CRVS Director, 10% owner · APTX Director, 10% owner · ICVX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-12-06 | 2023-12-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-06-15 | 2023-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-08-11 | 2022-08-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-06-15 | 2022-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-09-09 | 2021-09-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 3,631,066 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 79,734 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 171,505 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 3,509,939 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,042,120 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,348,119 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 2,013,269 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 935,985 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 309,321 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 299,003 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 88,775 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 114,843 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | P Buy | 2021-08-02 | 2021-08-03 | 47,981 | $15.00 | $719.7K | 996,169 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 352,037 | — | $0 | 352,037 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 272,131 | — | $0 | 272,131 | SEC↗ |
| ICVX Icosavax, Inc. | P Buy | 2021-08-02 | 2021-08-03 | 46,381 | $15.00 | $695.7K | 962,939 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 916,558 | — | $0 | 916,558 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 525,729 | — | $0 | 525,729 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 948,188 | — | $0 | 948,188 | SEC↗ |
| ICVX Icosavax, Inc. | P Buy | 2021-08-02 | 2021-08-03 | 12,368 | $15.00 | $185.5K | 256,783 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 244,415 | — | $0 | 244,415 | SEC↗ |
| ICVX Icosavax, Inc. | P Buy | 2021-08-02 | 2021-08-03 | 26,604 | $15.00 | $399.1K | 552,333 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2021-05-27 | 2021-06-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-12-31 | 2021-01-05 | 4,496 | $2.22 | $10.0K | 4,496 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-09-30 | 2020-10-02 | 4,623 | $2.16 | $10.0K | 4,623 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-06-30 | 2020-07-02 | 3,735 | $2.68 | $10.0K | 3,735 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-06-09 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-05-20 | 2020-05-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2020-03-31 | 2020-04-02 | 7,374 | $1.36 | $10.0K | 7,374 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-03-19 | 2020-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-12-31 | 2020-01-03 | 4,668 | $2.14 | $10.0K | 4,668 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-09-30 | 2019-10-02 | 4,802 | $2.08 | $10.0K | 4,802 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-06-28 | 2019-07-02 | 5,046 | $1.98 | $10.0K | 5,046 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-06-20 | 2019-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-05-15 | 2019-05-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-03-29 | 2019-04-02 | 4,123 | $2.43 | $10.0K | 4,123 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 4,406,861 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 5,036,369 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,347,072 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,333,558 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,809,747 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 11,551,579 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,032,316 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,465,474 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 2,303,087 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,977,704 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 2,643,505 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 7,676,955 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 10,107,719 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 2,531,884 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 4,534,213 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 5,181,913 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,443,798 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 3,480,521 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 91,781 | — | $0 | 390,165 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 138,103 | — | $0 | 298,384 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 120,841 | — | $0 | 160,281 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 22,877 | $16.00 | $366.0K | 538,664 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 121,331 | — | $0 | 515,787 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 182,568 | — | $0 | 394,456 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 159,749 | — | $0 | 211,888 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 52,471 | $16.00 | $839.5K | 1,115,910 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 278,290 | — | $0 | 1,063,439 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 418,745 | — | $0 | 785,149 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 366,404 | — | $0 | 366,404 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 17,305 | $16.00 | $276.9K | 407,470 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 164,365 | — | $0 | 218,011 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 187,844 | — | $0 | 405,855 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 126,168 | — | $0 | 126,168 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 15,741 | $16.00 | $251.9K | 334,772 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 83,487 | — | $0 | 319,031 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 125,623 | — | $0 | 235,544 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 109,921 | — | $0 | 109,921 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 18,068 | $16.00 | $289.1K | 384,255 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 95,827 | — | $0 | 366,187 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 144,192 | — | $0 | 270,360 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 124,838 | — | $0 | 530,693 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 23,538 | $16.00 | $376.6K | 554,231 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2018-06-21 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-03-12 | 2018-03-13 | 69,864 | $8.50 | $593.8K | 69,864 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-03-12 | 2018-03-13 | 236,128 | $8.50 | $2.01M | 236,128 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-03-12 | 2018-03-13 | 67,769 | $8.50 | $576.0K | 67,769 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-03-12 | 2018-03-13 | 87,668 | $8.50 | $745.2K | 87,668 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-03-12 | 2018-03-13 | 126,806 | $8.50 | $1.08M | 126,806 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2017-06-08 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 567,121 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 92,278 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 550,864 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 71,863 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 583,510 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 97,746 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 95,001 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 428,998 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-03-29 | 2016-03-29 | 53,239 | $15.00 | $798.6K | 715,361 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 95,001 | — | $0 | 662,122 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 567,121 | — | $0 | 567,121 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-03-29 | 2016-03-29 | 51,712 | $15.00 | $775.7K | 694,854 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 92,278 | — | $0 | 643,142 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 550,864 | — | $0 | 550,864 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 428,998 | — | $0 | 428,998 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-03-29 | 2016-03-29 | 54,777 | $15.00 | $821.7K | 736,033 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 97,746 | — | $0 | 681,256 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 583,510 | — | $0 | 583,510 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-03-29 | 2016-03-29 | 40,272 | $15.00 | $604.1K | 541,133 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 71,863 | — | $0 | 500,861 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-03-22 | 2016-03-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 2,939 | — | $0 | 12,046 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 22,125 | — | $0 | 90,349 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 14,695 | — | $0 | 59,567 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 39,017 | — | $0 | 125,060 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 7,026 | — | $0 | 28,691 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 9,205 | — | $0 | 37,591 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 24,631 | — | $0 | 82,395 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 2,431 | — | $0 | 7,294 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 782 | — | $0 | 2,346 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 1,166 | — | $0 | 3,498 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 19,666 | — | $0 | 59,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 14,118 | — | $0 | 42,355 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-11-30 | 2015-12-02 | 18,277 | — | $0 | 54,833 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 26,762 | — | $0 | 68,224 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 8,499 | — | $0 | 21,665 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 11,135 | — | $0 | 28,386 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 17,775 | — | $0 | 44,872 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 3,555 | — | $0 | 9,107 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 27,218 | — | $0 | 57,764 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 2,432 | — | $0 | 4,863 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 782 | — | $0 | 1,564 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 1,166 | — | $0 | 2,332 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 19,667 | — | $0 | 39,334 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 14,119 | — | $0 | 28,237 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 18,278 | — | $0 | 36,556 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-02-24 | 2015-02-26 | 43,022 | — | $0 | 86,043 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 18,278 | — | $0 | 18,278 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 17,775 | — | $0 | 27,097 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 26,761 | — | $0 | 41,462 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 8,498 | — | $0 | 13,166 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 11,134 | — | $0 | 17,251 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 43,021 | — | $0 | 43,021 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 3,555 | — | $0 | 5,552 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 14,118 | — | $0 | 14,118 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 19,667 | — | $0 | 19,667 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 1,166 | — | $0 | 1,166 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 782 | — | $0 | 782 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 2,431 | — | $0 | 2,431 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2015-01-09 | 2015-01-13 | 27,217 | — | $0 | 30,546 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2015-01-13 | 3,002 | — | $0 | 6,117 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2015-01-13 | 2,291 | — | $0 | 4,668 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2015-01-13 | 7,215 | — | $0 | 14,701 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2015-01-13 | 1,634 | — | $0 | 3,329 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2015-01-13 | 980 | — | $0 | 1,997 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2015-01-13 | 4,575 | — | $0 | 9,322 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-06-18 | 2014-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2015-01-13 | 3,115 | — | $0 | 3,115 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2015-01-13 | 2,377 | — | $0 | 2,377 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2015-01-13 | 7,486 | — | $0 | 7,486 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2015-01-13 | 1,695 | — | $0 | 1,695 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2015-01-13 | 1,017 | — | $0 | 1,017 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2015-01-13 | 4,747 | — | $0 | 4,747 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 348,652 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 270,811 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 293,098 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 322,142 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 322,142 | — | $0 | 592,953 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 270,811 | — | $0 | 270,811 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 348,652 | — | $0 | 641,750 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 293,098 | — | $0 | 293,098 | SEC↗ |